Research Article
Association between Sleep Disruption and Levels of Lipids in Caucasians with Type 2 Diabetes
Table 1
Baseline characteristics based on sleep quality.
| | GQ () | PQ () | Sig |
| Female | 20 (31.7) | 32 (62.7) | 0.002 | Antihypertensive | 45 (71.4) | 43 (84.3) | 0.16 | Lipid lowering | 30 (47.6) | 22 (43.1) | 0.773 | Oral antidiabetic | 41 (66.1) | 34 (65.4) | 1.0 | Insulin | 14 (22.6) | 8 (15.4) | 0.522 | Diet controlled | 13 (21) | 8 (15.4) | 0.664 | Age (years) | 64.0 ± 11.32 | 66.0 ± 10.98 | 0.339 | Weight (kg) | 86.63 ± 21.65 | 83.25 ± 16.26 | 0.358 | BMI (kg/m2) | 30.59 ± 7.3 | 30.84 ± 4.36 | 0.835 | SBP (mmHg) | 137.30 ± 18.75 | 147.16 ± 17.67 | 0.005 | DBP (mmHg) | 76.43 ± 12.26 | 80.04 ± 10.35 | 0.097 | Glucose (mmol/L) | 7.2 (5.9–8.5) | 7.3 (6.7–9.4) | 0.169 | HbA1c | | | | (%) | 6.1 (5.5–7.2) | 6.8 (6.2–7.6) | 0.026 | mmol/mol | 43.2 (36.6–55.2) | 50.8 (44.3–59.6) | UAC (mg/mmol) | 8.11 (3.12–33.1) | 18.02 (8.19–44.27) | 0.03 | Total cholesterol (mmol/L) | 4.50 ± 0.87 | 4.87 ± 0.87 | 0.025 | TG (mmol/L) | 1.38 (0.97–2.07) | 1.69 (1.26–2.44) | 0.026 | HDL (mmol/L) | 1.21 ± 0.29 | 1.28 ± 0.34 | 0.249 | LDL (mmol/L) | 2.51 ± 0.62 | 2.73 ± 0.72 | 0.097 | Sleep duration (h) | 7.25 ± 0.95 | 5.57 ± 1.49 | <0.001 |
|
|
SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; HbA1c: glycated haemoglobin; UAC: urinary albumin : creatinine ratio; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein. Genders, treatment with antihypertensive, lipid-lowering agents, oral antidiabetic medications, insulin, and diet controlled are expressed in (%).
|